2015/2016 Annual Donor Impact Report
Total Page:16
File Type:pdf, Size:1020Kb
MORE TOMORROWS More Memories Together 2015-16 ANNUAL REPORT CancerCare Manitoba Foundation (CCMF) fundraises exclusively for CancerCare More Manitoba (CCMB). Since 2000, through the generous support of thousands of Memories caring Manitobans, the Foundation has granted more than $98 million to help CCMB deliver the best research, treatment, Together patient care and support. This year Manitobans continued to trust CCMF with their donations. We are INSIDE: CancerCarestewards of theseManitoba dollars Foundation and are so proud raisesto tell donorsfunds exclusively exactly how for and CancerCare where their 1 Message from the Chair and CEO Manitobamoney was (CCMB). spent. This Since report 2000 is thefor the 2 Donor Dollar Impact Foundationfiscal year hasending donated March more 31, 2016.than $91 million to CCMB to support our shared 3 A Journey of Milestones vision of reducing the impact of cancer on 6 Next Generation: Driving Research Forward all Manitobans and their families affected by cancer. 7 Clinical Trials / Prevention & Early Detection This year Manitobans continued to trust the 8 AfterCare Program Foundation with their donations. We are 9 stewards of these dollars and are proud to tell Signature Events donors exactly how and where their money 11 Individual Donors was spent. This report is for the fiscal year ending March 31, 2015. 14 Corporate Donors 16 Community Events On the cover: A Journey of Milestones. Carl Bittner pictured with his wife and daughters 19 Our Board and Committees 20 Financial Statements Together we accomplished so much. Our valued donors, volunteers and sponsors – YOU made this year outstanding. We are truly grateful for your incredible and unwavering support. Your contributions – financial and time – profoundly impacted our ability to help CancerCare Manitoba accomplish its goals. On behalf of the Board of Directors, we are pleased to share the annual report for the year ending March 31, 2016. The Foundation is the only charitable organization exclusively fundraising for CancerCare Manitoba. Every precious dollar you gift to us stays in the province and helps cancer patients and their families. Your generosity allowed us to grant over $6.7 million this year to CancerCare to support prevention and detection initiatives, groundbreaking research, clinical trials and patient care programs and services. In the pages ahead you will read Carl Bittner’s inspiring story. A husband, father of three and a man with a contagious personality, Carl has lived with melanoma for sixteen years. And has he EVER TRULY LIVED! Originally given a 10 per cent chance of survival, Carl has endured many different surgeries and treatments. The tremendously gifted team at CancerCare Manitoba has been with him every step of the way along his journey. He has beat the odds and our generous donors – individual, corporate and community fundraisers – should be so proud that your support has provided Carl and many other patients with the opportunity to experience more memories together with their loved ones and friends. We are so fortunate to be the beneficiary of the amazing community spirit and philanthropy that Manitoba is recognized for across the country. Thank you for your continued support and belief in the work we do. You touch our hearts and the hearts of Manitoba’s cancer patients. Doug Harvey, CHAIR Annitta Stenning, PRESIDENT AND CEO CANCERCARE MANITOBA FOUNDATION CANCERCARE MANITOBA FOUNDATION BOARD OF DIRECTORS 1 Specific projects funded in 2015-2016: DONOR RESEARCH, EDUCATION & EQUIPMENT Core Operating Budget – Research Institute in Oncology and Hematology DOLLAR Research Operating Grants Studentships and Fellowships CCMB Translational Research Program IMPACT Core funding for CancerCare Manitoba training programs Manitoba Palliative Care Research Unit Infrastructure Support EPIDEMIOLOGY AWARENESS & Equipment – Automatic Immunohistology Staining System 6% RISK REDUCTION and High-Throughput Flow Cytometer 4% EPIDEMIOLOGY Core funding for Epidemiology and Cancer Registry PATIENT CARE, PEDIATRIC AND ADULT CLINICAL TRIALS SUPPORT Core funding for Pediatric and Adult Clinical Trials AND TRAINING RESEARCH, 15% EDUCATION PATIENT CARE – SUPPORT AND TRAINING & EQUIPMENT Camp Indigo – Pediatric Oncology PEDIATRIC 57% AND ADULT Cancer Specific Information and Networking Sessions CLINICAL TRIALS Cancer Patient Handbook 18% CCMB AfterCare Program for survivors of childhood cancer Community Oncology Professional Development Awards Community Cancer Care Educational Conference Community Oncology Program Transitions Initiative Compression Garments for Sarcoma Patients Consultation Recording Service for Patient Support The Foundation’s mandate is to support Digital Mobile Mammography Coach CancerCare Manitoba’s strategic priorities Enhanced Quality of Life and Supportive Care Programming by funding programs and services that may Expansion of Breast Cancer Centre of Hope to include support not be eligible for government funding. for gynecological cancers Guardian Angel Caring Room CancerCare Manitoba Foundation’s Board of Directors takes its donor stewardship Manitoba Teens Living with Cancer responsibilities very seriously. Annually the Board Mobility and Self-Management Program considers peer-reviewed research and program Music To My Ears proposals submitted by CCMB which align with Palliative Care Initiatives for health-care providers, its strategic plan. Funding requests are thoughtfully patients and families reviewed by the Foundation’s Project, Grants Patient and Family Resource Centre & Awards Committee and are recommended Patient and Family Refreshment Services for approval. Pediatric Oncology Program – Education Grant This fiscal year the Foundation provided Perfusion Pump $6.7 million in funding to support CancerCare The Navigator Newsletter Manitoba’s strategic priorities. Volunteer and Community Based Information and Support Programs Web-Based Thyroid Cancer Modeling 2 CANCERCARE MANITOBA FOUNDATION ANNUAL REPORT 2015-2016 A Journey of Milestones Carl Bittner is an example He would have to lean on that outlook Carl’s journey started in 2000. While as his fight took many twists and working in the theatre business, he of what the leading-edge of turns. His cancer came back again noticed a small lesion inside his nose, cancer treatment truly is. and again during the past sixteen and was referred to a specialist. What years, with Carl and his CancerCare he originally thought might be a polyp Carl embodies the multitude Manitoba team having to pivot their turned out to be so much more. The of options available to cancer patients approach as new developments arose. lesion was removed and submitted receiving treatment at CancerCare for testing. The doctor called him back Manitoba. Carl’s case exemplifies When recounting his story, he is open – the news – “you have melanoma.” how critical a clinical trial can be for and unflinching, and always positive In an instant, his life was turned on its a positive outcome. And Carl is an and quick to interlace his good- heels. A husband and father of three illustration of a life lived with a positive natured humour into any anecdote. kids, he was now also a cancer patient. attitude and the impact that positivity A lot of that outlook can be attributed can have on a cancer patient journey. to his support system. Although melanoma comprises only four per cent of all skin cancers, it is Throughout Carl’s experience, he has “The three F’s: faith, family and friends. responsible for 80 per cent of skin always prided himself on the fact he I had lots of that. I was surrounded by cancer-related deaths worldwide. has had zero hesitation. Whatever everything I needed. I got used to Melanoma originates from pigment- needed to get done, he was ready dealing with the lows, and when it was producing cells called melanocytes, to tackle it head on. “As aggressive hard to go on I told myself ‘I can keep located in the skin. Most forms of as cancer is, you’ve got to hit it back doing this,’” said Carl. “I don’t know melanoma occupy only the top layer just as aggressively,” he said. if it was a coping mechanism, but you of the skin. If it penetrates deeper, it is learn not to get your hopes up too far more dangerous, as it can spread high, but in the same token, don’t to other areas of the body. let it paralyze you.” 3 “Some people are frightened by treatment. It’s hard to undergo physical tests to see if he could withstand the treatment to process,” said Carl. “For me, if Dr. Wong says let’s itself, as not every patient can handle do this, then bam, let’s do this!” it. The side effects of the treatment are severe but he faced them with his The upbeat Carl however, was not melanoma and other cancers. He took usual ‘can do’ attitude. He was flustered by his diagnosis. “I was high doses of it, and was in outpatient admitted to the intensive care unit feeling great, I was fine. I said ‘yeah, intravenous every day for the first four for a week, where he was given a dose let’s do this.’” His positivity remained weeks. After that, he gave himself a of the medicine. He was constantly despite being told he only had a shot three to five times a week for the monitored for any problems with his 10 per cent chance of survival. rest of the year. Carl fought through health, and then once eight hours had the side effects, went for scans every passed and his vitals were in order, Carl underwent an intricate 12-hour few months, and soon five years had he would receive another dose, and operation which had to be carried passed. His melanoma was not just repeat the experience. He had two out in stages. The surgical team had some hazard in the rear-view mirror weeks to recover, and then it started to perform a wide excision to remove though, as there were many again for another week. the melanoma and a margin of roadblocks still ahead. normal skin around it. A frozen Even Carl admits, “the process was culture was taken and sent for testing.